(19)
(11) EP 3 283 884 A1

(12)

(43) Date of publication:
21.02.2018 Bulletin 2018/08

(21) Application number: 16780678.5

(22) Date of filing: 13.04.2016
(51) International Patent Classification (IPC): 
G01N 33/564(2006.01)
A61K 35/74(2015.01)
 G06F 19/22(2011.01)
C12Q 1/68(2018.01)
(86) International application number:
PCT/US2016/027371
(87) International publication number:
WO 2016/168364 (20.10.2016 Gazette 2016/42)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 13.04.2015 US 201562146846 P
13.04.2015 US 201562146818 P
14.04.2015 US 201562147345 P
14.04.2015 US 201562147324 P
14.04.2015 US 201562147348 P
14.04.2015 US 201562147328 P
14.04.2015 US 201562147334 P
14.04.2015 US 201562147287 P

(71) Applicant: Ubiome Inc.
San Francisco, CA 94103 (US)

(72) Inventors:
  • APTE, Zachary
    San Francisco, CA 94103 (US)
  • ALMONACID, Daniel
    San Francisco, CA 94103 (US)
  • RICHMAN, Jessica
    San Francisco, CA 94103 (US)
  • BEHBAHANI, Siavosh, Rezvan
    San Francisco, CA 94103 (US)

(74) Representative: Stanners, David Ralph 
Urquhart-Dykes & Lord LLP Altius House 1 North Fourth Street
Milton Keynes MK9 1NE
Milton Keynes MK9 1NE (GB)

   


(54) METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR AUTOIMMUNE SYSTEM CONDITIONS